| Theme | Clinical Pathway for Digestive Diseases | |
|---|---|---|
| Title | The Significance of the Clinical Pathway in Japan | |
| Publish Date | 2002/05 | |
| Author | Hironobu Suko | Saiseikai Kumamoto Hospital |
| Author | Hidehisa Soejima | Saiseikai Kumamoto Hospital |
| [ Summary ] | From a patients, viewpoint of it is highly significant that the clinical path approach has displaced former exclusive clinical practices with the open sharing of medical information. Furthermore, variance analysis of the path can clarify not only the process of medical treatment but also problems with the medical system at hospitals. The path is also beneficial for the control of treatment risk and medical cost and it is expected to contribute to more efficient and qualified medical practice in the future. In our country, there remain many problems to be resolved, such as the disclosure of the medical information, fair medical costs, effective medical provisions, and the introduction of the Japanese-Modified DRG/PPS (diagnosis related groups/prospective payment system). Thinking of the background of these problems, it is inevitable that the clinical path approach has become widespread in relation to EBM (evidence based medicine), accompanied with a computerized medical record system. |
|